# A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

> **NCT00666900** · PHASE2 · COMPLETED · sponsor: **Dow Pharmaceutical Sciences** · enrollment: 366 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Low Strength IDP-107
- **DRUG:** High Strength IDP-107
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT00666900
- **Lead sponsor:** Dow Pharmaceutical Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-03
- **Final completion:** 2009-09
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2012-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00666900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00666900, "A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00666900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*